Sanuwave Health Inc.

SNWV Healthcare Medical Devices

Sanuwave Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.1 million, up 35.0% from fiscal 2024. In the quarter to June 2026, revenue fell 3.13%, EPS fell 224.2%, free cash flow grew 86.8% and total debt fell 28.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

4.96 0.21 −4.06%
Market cap
$44.5M
P/E
3.0×
Fwd P/E
−211×
Dividend yield
—
F-score
6/9
Altman Z
−2.97
Beneish M
−0.90
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
4 5 6 5

+8 more TTM periods

ROE
(254.57%) (213.43%) (166.66%) 30.70%
ROA
43.82% 48.54% 35.02% (33.78%)
ROIC
7.46% 17.31% 26.60% 25.73%
Return on Tangible Assets
209.52% 218.00% 134.97% (192.10%)
Average Days of Receivables
48.10 49.39 44.93 40.97
Free Cash Flow per Share
1.09 1.07 0.85 0.49
Free Cash Flow
9.37 9.23 7.31 4.22
Other line items

Show all line items

Columns are period end dates